Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hobart
Clinical trial register · Australia

Clinical Trials in Hobart, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Regeneron Pharmaceuticals5 Pfizer5 AbbVie4 Janssen Research & Development, LLC4 AstraZeneca4
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Hobart

102 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Menzies Institute for Medical Research
Not applicable
6,000
Hobart
2026-10
Recruiting
AstraZeneca
Phase 3
950
Auchenflower, Benowa, Hobart, Kingswood, Nedlands, Port Macquarie, Randwick, Richmond
2026-09-16
Recruiting
A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery
NCT07694375Corneal Endothelial Cell Loss, Corneal Endothelial Damage Following the Hard Nuclear Cataract Surgery
Caravel Oculus Pty Ltd
Phase 2
200
Deakin, Baulkham Hills, Blacktown, Eastwood, Sydney, Adelaide, Hobart, Launceston
2026-07-28
Recruiting
Regeneron Pharmaceuticals
Phase 2
99
Brisbane, South Brisbane, Hobart
2026-05-06
Not yet open
Statins Against Bushfire Smoke
NCT07462715Healthy Adults
DrugAtorvastatin
Menzies Institute for Medical Research
Phase 4
100
Hobart
2026-05-01
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
NCT07285655Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc.
Phase 3
344
Hobart
2026-04-23
Not yet open
Peter MacCallum Cancer Centre, Australia
Observational
75
Camperdown, Sydney, Adelaide, Hobart, Box Hill, Clayton, Melbourne, Nedlands
2026-04-08
Recruiting
University of Tasmania
Not applicable
577
Hobart, Melbourne
2026-04-01
Recruiting
Genmab
Phase 2
240
Adelaide, Camperdown, Hobart, Hyde Park, Murdoch, Saint Leonards
2026-01-30
Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322IDH-mutant Grade 2 or 3 Astrocytoma
DrugVorasidenib
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
468
Bedford Park, Camperdown, Heidelberg, Hobart, Liverpool, Melbourne, Nedlands, St Leonards
2026-01-16
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Kingswood, St Leonards, Birtinya, Gympie, Nambour, South Brisbane, Elizabeth Vale, Hobart
2026-01-06
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Liverpool, St Leonards, Birtinya, Brisbane, Elizabeth Vale, Hobart, Ballarat Central, Garran
2026-01-02
Recruiting
Eli Lilly and Company
Phase 3
800
Ballarat Central, Brisbane, Darlinghurst, Hobart, Melbourne, Newcastle, North Ryde, Shepparton
2025-12-22
Recruiting
Pfizer
Phase 3
800
Buderim, Woodville South, Hobart, Clayton, Melbourne
2025-12-11
Recruiting
AbbVie
Phase 2/3
490
Garran, Kogarah, South Brisbane, Hobart, Fitzroy, St Albans, Nedlands
2025-12-10
Recruiting
Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
NCT06935890Allergy, Immunotherapy, Venom Allergy
Murdoch Childrens Research Institute
Phase 4
100
Adelaide, Hobart, Clayton
2025-11-25
Recruiting
AbbVie
Phase 2
400
Kogarah, Sydney, Auchenflower, Adelaide, Hobart, Clayton, Geelong, Melbourne
2025-11-13
Recruiting
Incyte Corporation
Phase 2
160
Blacktown, Concord, Adelaide, Hobart
2025-11-12
Recruiting
Hoffmann-La Roche
Phase 3
600
Darlinghurst, Liverpool, Waratah, Birtinya, Hobart, Clayton, Heidelberg, Melbourne
2025-10-24
Recruiting
Pfizer
Phase 2/3
982
Nowra, Westmead, Kurralta Park, Hobart, St Albans
2025-10-03
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Darlinghurst, Liverpool, Westmead, Woolloongabba, Adelaide, Hobart, Clayton, Melbourne
2025-10-02
Recruiting
Pfizer
Phase 3
680
Waratah, Westmead, Hobart, Ballarat
2025-09-29
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Box Hill, Camperdown, Chermside, Elizabeth Vale, Frankston, Frenchs Forest, Heidelberg, Hobart
2025-09-08
Recruiting
Celgene
Phase 3
400
Westmead, Adelaide, Hobart, Heidelberg, Malvern, Perth
2025-07-28
Recruiting
Optimal Implementation of Antimicrobial Stewardship in General Practice
NCT06953804The Use of Antimicrobial Stewardship in in General Practice (Family Medicine), Respiratory Tract Infections (RTI)
University of Wollongong
Not applicable
120
Wollongong, Gold Coast, Hobart, Melbourne
2025-07-01
Recruiting
Novo Nordisk A/S
Phase 2
200
Concord, Brisbane, Adelaide, Bedford Park, Hobart, Clayton, Murdoch
2025-06-30
Recruiting
Kiora Pharmaceuticals, Inc.
Phase 2
28
Sydney, Westmead, Adelaide, Hobart, East Melbourne, Nedlands
2025-05-01
Recruiting
AstraZeneca
Phase 3
830
Hobart, Woolloongabba
2025-04-10
Recruiting
Daiichi Sankyo
Phase 3
582
Adelaide, Auchenflower, Hobart, St Leonards, Sydney, Townsville
2025-03-19
Recruiting
BioNTech SE
Phase 2
60
Liverpool, Woolloongabba, Adelaide, Hobart, Nedlands
2025-03-03
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Camperdown, Penrith, St Leonards, Woolloongabba, Bedford Park, Hobart, Box Hill, Melbourne
2025-01-15
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Adelaide, Bankstown, Box Hill, Coffs Harbour, Hobart, Kurralta Park, Traralgon, Waratah
2025-01-03
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
NCT06561048Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
DrugsBelinostat·Pralatrexate·Soquelitinib
Corvus Pharmaceuticals, Inc.
Phase 3
150
Darlinghurst, Kogarah, South Brisbane, Adelaide, Bedford Park, Hobart, Box Hill, Heidelberg
2024-10-02
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Lismore, Westmead, Wollstonecraft, Douglas, Hervey Bay, Bedford Park, Woodville, Hobart
2024-09-18
Active, closed
Tectonic Therapeutic
Phase 2
191
Camperdown, Macquarie, New Lambton, Sydney, Wollongong, Chermside, Hobart, Malvern
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Auchenflower, Fitzroy, Hobart
2024-09-03
Recruiting
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
NCT06208657Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Recurrent Cancer
DrugsPaxalisib·Opdualag·Temozolomide·Irinotecan
Australian & New Zealand Children's Haematology/Oncology Group
Phase 1/2
90
Newcastle, Sydney, Brisbane, Adelaide, Hobart, Melbourne, Perth
2024-07-10
Recruiting
Allogene Therapeutics
Phase 2
250
Waratah, Auchenflower, Hobart, Clayton, Fitzroy, Heidelberg, Nedlands
2024-06-18
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Hobart, Nedlands, Adelaide, Clayton, Douglas, Gosford, Kogarah, Melbourne
2024-06-03
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
61
Randwick, Prahran, Douglas, Hobart
2024-04-29
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Camperdown, Chermside, Clayton, Hobart, Hyde Park
2024-02-26
Active, closed
Kyowa Kirin Co., Ltd.
Phase 2
185
Albury, Liverpool, Parramatta, Strathfield, Sydney, Adelaide, Hobart, East Melbourne
2024-01-09
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Liverpool, Waratah, Benowa, Hobart, East Melbourne
2023-12-28
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Maroochydore, Woodville South, Hobart
2023-10-27
Recruiting
Baker Heart and Diabetes Institute
Observational
748
Hobart, Melbourne
2023-10-18
Recruiting
Abbott Medical Devices
Observational
1,000
Adelaide, Hobart, Melbourne
2023-09-29
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Camperdown, St Leonards, Auchenflower, Herston, Adelaide, Hobart, Launceston, Fitzroy
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Concord, Randwick, Douglas, Woolloongabba, Bedford Park, Hobart, Box Hill, Fitzroy
2023-09-18
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
NCT05365659B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma
Iksuda Therapeutics Ltd.
Phase 1
140
Westmead, Adelaide, Hobart, Perth
2023-09-05
Active, closed
Gilead Sciences
Phase 3
654
Queensland, Darlinghurst, Liverpool, St Leonards, Auchenflower, Bedford Park, Hobart, Melbourne
2023-05-08
Active, closed
Pfizer
Phase 3
624
Coffs Harbour, Birtinya, Woolloongabba, Kurralta Park, Hobart, Brighton, Geelong, Malvern
2023-03-03
Recruiting
Monash University
Phase 4
9,180
Sydney, Brisbane, Adelaide, Hobart, Melbourne, Nedlands, Perth
2023-02-07
Active, closed
Silence Therapeutics plc
Phase 1/2
69
Benowa, Hobart, Kurralta Park, Melbourne, Nedlands, Richmond
2023-01-26
Recruiting
Jazz Pharmaceuticals
Phase 3
510
Randwick, Sydney, Herston, Hobart, Heidelberg, Nedlands
2023-01-23
Recruiting
Precision Medicine for Every Child With Cancer
NCT05504772Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Childhood Leukemia
Australian & New Zealand Children's Haematology/Oncology Group
Observational
3,500
Adelaide, Brisbane, Hobart, Melbourne, Newcastle, Perth, Sydney
2022-12-16
By invitation
Ionis Pharmaceuticals, Inc.
Phase 3
1,400
Joondalup, Murdoch, Clayton, Hobart, Leabrook, Liverpool, Westmead, Woolloongabba
2022-11-30
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ballarat Central, Box Hill, Clayton, Coffs Harbour, Darlinghurst, Geelong, Hobart, Launceston
2022-10-04
Recruiting
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
NCT05465174Craniopharyngioma, Child, Craniopharyngioma, Recurrent Craniopharyngioma
DrugTovorafenib
Sabine Mueller, MD, PhD
Phase 2
57
New Lambton Heights, Hobart, Clayton, Parkville, Nedlands
2022-09-12
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Maroochydore, Woodville South, Hobart
2022-08-04
Active, closed
Gilead Sciences
Phase 3
443
Albury, Kogarah, North Sydney, St Leonards, South Brisbane, Woolloongabba, Adelaide, Hobart
2022-07-25
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Southport, Townsville, North Adelaide, Hobart, Geelong, Melbourne
2022-07-14
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
529
Phillip, Maroochydore, Hobart
2022-06-30
Active, closed
Gilead Sciences
Phase 3
603
Albury, Bowral, Darlinghurst, Birtinya, Greenslopes, Bedford Park, Hobart, Box Hill
2021-11-17
Active, closed
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386Amyloid Cardiomyopathy, Transthyretin-Related
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
389
Darlinghurst, Woolloongabba, Adelaide, Hobart, Box Hill, Murdoch
2021-10-27
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Adelaide, Frankston, Hobart, Melbourne, Perth
2021-09-20
Active, closed
Janssen Research & Development, LLC
Phase 4
411
Camberwell, Hobart, Liverpool, Maroochydore, Melbourne
2021-08-30
Active, closed
Bristol-Myers Squibb
Phase 3
670
Phillip, Botany, Westmead, Woolloongabba, Hobart, Camberwell
2021-07-13
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
Adelaide, Hobart, Melbourne, Sunshine Coast
2021-06-17
Recruiting
Nutrition in Paediatric Critical Care
NCT06695078ICU, Nutrition, Paediatric
Australian and New Zealand Intensive Care Research Centre
Observational
200
Adelaide, Brisbane, Hobart, Melbourne, Perth, Sunshine Coast, Sydney
2021-06-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Camperdown, Chermside, Darlinghurst, New Lambton Heights, Adelaide, Hobart, Murdoch
2021-05-12
Active, closed
Geron Corporation
Phase 3
327
St Leonards, Herston, Hobart, Richmond
2021-04-12
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Kogarah, Hobart, Nedlands, Perth, Auchenflower
2021-04-08
Recruiting
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
NCT05194787Alzheimer Disease, Dementia, Age-related Cognitive Decline
University of Tasmania
Observational
3,000
Hobart
2021-03-05
Active, closed
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
NCT04594642B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma
DrugSurovatamig
AstraZeneca
Phase 1
226
Heidelberg, Hobart, Melbourne
2021-03-02
Active, closed
Celgene
Phase 3
313
Clayton, Melbourne, Nedlands, Gosford, Hobart
2021-02-25
Active, closed
GlaxoSmithKline
Phase 2/3
758
South Brisbane, Ashford, Hobart, Ballarat, Melbourne, Mount Waverley
2020-12-08
Active, closed
AbbVie
Phase 1
21
Douglas, Hobart, Perth
2020-11-11
Active, closed
Acerta Pharma BV
Phase 3
611
Adelaide, Camperdown, Darlinghurst, Heidelberg, Hobart, Kogarah, Nedlands, Westmead
2020-10-08
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Birtinya, Darlinghurst, Herston, Hobart, Kurralta Park, Liverpool, Melbourne, Murdoch
2020-09-23
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
Gosford, Hamlyn Terrace, Hobart, Nedlands, Adelaide, Eastwood, St Leonards
2020-08-20
Recruiting
Nordic Lymphoma Group
Phase 3
300
Albury, Camperdown, Coffs Harbour, Concord, Cudgen, Garran, Hobart, Liverpool
2020-08-19
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
296
Phillip, Hobart
2020-07-01
Active, closed
Actelion
Phase 3
935
Bedford Park, Camperdown, Chermside, Darlinghurst, Hobart, Murdoch, Westmead
2020-06-30
Active, closed
Epizyme, Inc.
Phase 3
599
Adelaide, Bedford Park, Clayton, Geelong, Nedlands, Frankston, Hobart, Southport
2020-06-11
Active, closed
GlaxoSmithKline
Phase 3
325
Gosford NSW, Liverpool, St Leonards, Woodville, Hobart, Clayton, Fitzroy, Geelong
2020-04-02
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Adelaide, Brisbane, Camperdown, Douglas, Geelong, Gosford, Hobart, Melbourne
2019-12-20
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Camperdown, Darlinghurst, Sydney, Chermside, Woolloongabba, Hobart, Fitzroy, Melbourne
2019-09-23
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Chermside, Milton, Taringa, Hobart, Geelong, Heidelberg, Melbourne
2019-09-20
Active, closed
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
NCT07224347Functional Disability, Dementia, Heart Disease, Stroke
Anne Murray
Observational
19,114
Garran, Wollongong, Adelaide, Mount Gambier, Burnie, Hobart, Launceston, Bendigo
2019-07-15
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Adelaide, Brisbane, Camperdown, Canberra, Douglas, Hobart, Launceston, Melbourne
2019-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Adelaide, Benowa, Birtinya, Brisbane, Darlinghurst, Hobart, Macquarie University, Malvern
2019-01-25
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Clayton, Concord, Fitzroy, Herston, Hobart, Kogarah, Malvern, Nedlands
2018-06-26
Active, closed
Acerta Pharma BV
Phase 3
310
Adelaide, Box Hill, Frankston, Geelong, Gosford, Hobart, Kogarah, Murdoch
2017-02-02
Active, closed
AbbVie
Phase 2
120
East Albury, Waratah, Bedford Park, Hobart
2017-01-19
Active, closed
Eisai Inc.
Phase 3
1,069
Box Hill, Heidelberg, Hobart, Macquarie Park, South Brisbane, St Albans
2016-10-13
Active, closed
Institute of Cancer Research, United Kingdom
Phase 2
345
Wagga Wagga, Brisbane, Douglas, South Brisbane, Hobart, Melbourne, Nedlands
2015-10-21
Active, closed
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
NCT02099123Independent Living, Disability Free Survival, Elderly, Healthy
DrugsLipitor·Atorvastatin
Monash University
Phase 4
9,971
Hobart, Melbourne, Adelaide, Brisbane, Newcastle, Perth
2015-07
Active, closed
AstraZeneca
Phase 3
1,837
Adelaide, Auchenflower, Concord, Douglas, Gosford, Hobart, Malvern, Melbourne
2014-04-22
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Adelaide, Box Hill, Camperdown, Darlinghurst, Geelong, Gosford, Hobart, Kogarah
2013-10-14
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2/3
574
Newcastle, Sydney, Tweed Heads, Wollongong, Brisbane, Adelaide, Hobart, Launceston
2009-09
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
St Leonards, Sydney, Brisbane, Parkville, Bedford Park, Heidelberg, Hobart, Melbourne
2007-12
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Sydney, Westmead, Brisbane, Townsville, Adelaide, Hobart, Clayton, Parkville
1991-04-01
Rows per page Showing 1–102 of 102
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/hobart

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 102 of those studies with a site in Hobart.

How many clinical trials are recruiting in Hobart?

48 of the 102 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 49 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hobart), 102 studies
PhaseStudiesRecruitingShare
Phase 3572155.9%
Phase 2171216.7%
Observational867.8%
Phase 2/3534.9%
Phase 4524.9%
Phase 1/2413.9%
Not applicable322.9%
Phase 1312.9%

Most active sponsors

Lead sponsors with the most studies (Hobart)
Lead sponsorStudiesRecruiting
Pfizer54
Regeneron Pharmaceuticals53
AbbVie42
AstraZeneca42
Janssen Research & Development, LLC40
Gilead Sciences30
Loxo Oncology, Inc.31
Acerta Pharma BV20
Australian & New Zealand Children's Haematology/Oncology Group22
Bristol-Myers Squibb21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.